|
|
Volumn 57, Issue 13, 2000, Pages 1202-1204
|
|
FDA approves antibody-directed cytotoxic agent for acute myeloid leukemia
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CALICHEAMICIN;
CYTOTOXIC AGENT;
GEMTUZUMAB OZOGAMICIN;
UNCLASSIFIED DRUG;
ACUTE GRANULOCYTIC LEUKEMIA;
ADULT;
AGED;
ANEMIA;
BLEEDING;
BONE MARROW SUPPRESSION;
CANCER CHEMOTHERAPY;
CANCER RECURRENCE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG APPROVAL;
DRUG MECHANISM;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
LIVER TOXICITY;
MAJOR CLINICAL STUDY;
NOTE;
OPPORTUNISTIC INFECTION;
PRIORITY JOURNAL;
THROMBOCYTOPENIA;
TREATMENT OUTCOME;
|
|
EID: 0034235481
PISSN: 10792082
EISSN: None
Source Type: Journal
DOI: 10.1093/ajhp/57.13.1202a Document Type: Note |
|
Times cited : (5)
|
|
References (0)
|